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Working memory is a type of short-term memory involved in the maintenance and
manipulation of information essential for complex cognition. While memory span capacity
has been extensively studied in humans as a measure of working memory, it has received
considerably less attention in rodents. Our aim was to examine the role of the N-methyl-
D-aspartate (NMDA) and α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)
glutamate receptors in odor span capacity using systemic injections or infusions of
receptor antagonists into the medial prefrontal cortex (mPFC). Long Evans rats were
trained on a well-characterized odor span task (OST). Initially, rats were trained to dig
for a food reward in sand followed by training on a non-match to sample discrimination
using sand scented with household spices. The rats were then required to perform a
serial delayed non-match to sample procedure which was their odor span. Systemic
injection of the broad spectrum NMDA receptor antagonist 3-(2-Carboxypiperazin-4-
yl)propyl-1-phosphonic acid (CPP) (10 mg/kg) or the GluN2B-selective antagonist Ro 25-
6981 (10 mg/kg but not 6 mg/kg) significantly reduced odor span capacity. Infusions of the
GluN2B- selective antagonist Ro 25-6981 (2.5 μg/hemisphere) into mPFC reduced span
capacity, an effect that was nearly significant (p = 0.069). Infusions of the AMPA receptor
antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) (1.25 μg/hemisphere) into mPFC
reduced span capacity and latency for the rats to make a choice in the task. These results
demonstrate span capacity in rats depends on ionotropic glutamate receptor activation in
the mPFC. Further understanding of the circuitry underlying span capacity may aid in the
novel therapeutic drug development for persons with working memory impairments as a
result of disorders such as schizophrenia and Alzheimer’s disease.
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INTRODUCTION
Working memory, a type of short term memory, enables the
maintenance and manipulation of information needed for com-
plex cognitive functions (Goldman-Rakic, 1996; Baddeley, 2003;
D’Esposito, 2007). Working memory is impaired in numerous
brain disorders including schizophrenia (Barch et al., 2009) and
Alzheimer’s disease (Huntley and Howard, 2010); thus, the use
of appropriate preclinical working memory tasks in rodents to
understand the neural mechanisms underlying working memory
provides one approach for the development of novel therapeutics.
In animals, working memory has been assessed using a variety
of different tasks, many of which relate solely to the short-term
storage of information over delays, without assessment of the
capacity of working memory (Dudchenko, 2004; Dudchenko
et al., 2012). In schizophrenia, working memory capacity is
decreased (Chey et al., 2002; Gold et al., 2010) and the Cog-
nitive Neuroscience Treatment Research to Improve Cognition
in Schizophrenia (CNTRICS) group has identified capacity as a
component of working memory requiring more basic research
before being included in the translational battery (Barch and
Smith, 2008; Dudchenko et al., 2012).
Working memory capacity has been studied in rodents
using span tasks with odors or spatial locations as stimuli. One
of these tasks is the odor span task (OST) first developed by
Dudchenko et al. (2000) (Figure 1A). The OST is an incremental
non-match-to-sample task where rats or mice receive a food
reward by choosing to dig in a bowl of sand with the novel
scent (Dudchenko et al., 2000; Young et al., 2007; Rushforth
et al., 2010, 2011; Davies et al., 2013) or by moving scented lids
(MacQueen et al., 2011; April et al., 2013; Galizio et al., 2013).
Once the subject chooses the novel bowl, additional bowls are
added with the previous bowl(s) rearranged on the platform until
the subject chooses a previously rewarded bowl. The number of
bowls correctly discriminated minus 1 is the span of the subject.
Mean spans of approximately 7–9 odors have been reported
when rats are stopped after their first error (Dudchenko et al.,
2000; but see April et al., 2013; Davies et al., 2013). Span capacity
declines following reversible inactivation of the medial prefrontal
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FIGURE 1 | (A) Illustration of the OST. See text for details. Odors are
indicated with letters. On subsequent trials for a given span, the bowl (black
circle) that contains the novel odor is rewarded (+) while all previously
encountered stimuli are not (−). Bowls are added one at a time to the
platform until an error is made. The span is calculated as the number of
bowls on the platform for the last error free trial minus 1. Note that all bowls
are moved around the platform before each new trial. (B) Mean odor spans
during the 7 days of training immediately prior to the first treatment
(3-(2-Carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP); n = 8). (C) Mean
odor spans on the baseline sessions before each treatment in the within
subjects design (see Table 1). The GluN2B-selective NMDA receptor
antagonist Ro 25-6981 was given three times: first, 6 mg/kg (i.p.); second,
10 mg/kg (i.p.); and third, 2.5 μg/hemisphere. * Refers significantly lower
span relative to all other conditions (p < 0.05). Ro, Ro 25-6981.
cortex (mPFC; Davies et al., 2013), but not permanent lesions
of dorsal hippocampus (Dudchenko et al., 2000), in rats. Span
capacity is also reduced following exposure to acute stress (Davies
et al., 2013). Further research has demonstrated that odor span
capacity is increased by systemically administered nicotinic
receptor agonists (Rushforth et al., 2010) while it is transiently
reduced following 192 IgG-saporin-induced cholinergic lesions
of the basal forebrain (Turchi and Sarter, 2000). Odor span is also
impaired by non-competitive N-methyl-D-aspartate (NMDA)
receptor antagonists (MacQueen et al., 2011; Rushforth et al.,
2011; Galizio et al., 2013) and the γ -aminobutyric acid (GABA)
A receptor modulator chlordiazepoxide (Galizio et al., 2013).
Table 1 | Schedule of treatments during the experiment.
Week Stage
1 Habituation and dig training
2–3 Non-matching-to-sample
3–4 Odor span training
4–5 CPP (10 mg/kg; i.p.)
6 Ro 25-6981 (6 mg/kg; i.p.)
7 Washout
8 Ro 25-6981 (10 mg/kg; i.p.)
9–10 mPFC cannulae implantation and recovery
11 Ro 25-6981 (2.5 μg/hemisphere; mPFC)
12 CNQX (1.25 μg/hemisphere; mPFC)
Note that all drug treatments were paired with a vehicle treatment on the same
week.
Limited information exists regarding the effects of brain site-
specific modulation of neurotransmitters and their receptors on
working memory capacity as assessed by the OST. In one study,
working memory capacity was increased in transgenic mice over-
expressing the NMDA receptor subunit GluN2B in forebrain
areas including the cortex (Cui et al., 2011). A study exam-
ining the maintenance, but not capacity, of working memory
demonstrates a role of ionotropic glutamate receptors in the
dorsolateral prefrontal cortex for working memory in monkeys
(Wang et al., 2013). Using the delayed occulomotor response
task, Wang et al. (2013) showed that NMDA receptors containing
GluN2B subunits in the dorsolateral prefrontal cortex are essen-
tial for the maintenance of working memory by regulating the
activity of delay period neural activity during the task. Mixed
effects were found for the AMPA receptor antagonist 6-cyano-
7-nitroquinoxaline-2,3-dione (CNQX) in the same paradigm in
monkeys (Wang et al., 2013) and previous studies examining
working memory in rodents (Li et al., 1997; Romanides et al.,
1999).
Taken together, these findings suggest that ionotropic gluta-
mate receptors in the mPFC may be critical for span capacity. To
test this possibility, we used the OST in rats and first performed
systemic injections of the broad NMDA receptor antagonist CPP
(Lehmann et al., 1987) and the GluN2B-selective antagonist
Ro 25-6981 (Fischer et al., 1997). Subsequently, we used direct
intracranial infusions of Ro 25-6918 and the AMPA receptor
antagonist CNQX (Honore et al., 1988) targeted to the mPFC to
specify a role for receptors in that area in odor span capacity.
METHODS
ANIMALS
Eight adult male Long-Evans rats (270–310 g; Charles Rivers,
Quebec, Canada) were tested in the experiments using a within
subjects design (Table 1). For 6 days after arrival to the facility, the
rats were paired housed in clear plastic cages in a colony room on
a 12 h light/dark cycle (lights on at 07:00) with ad libitum access
to food (Purina Rat Chow) and water. Otherwise, the rats were
individually caged with ad libitum access to water and were food
restricted to maintain 85% of their free feeding weight (except for
several days before and after surgery when food was also available
ad libitum). All experiments were conducted in accordance with
the standards of the Canadian Council on Animal Care and were
approved by the University of Saskatchewan Animal Research
Ethics Board.
APPARATUS AND MATERIALS
Both training and testing occurred on a 91.5 cm2 black corru-
gated plastic platform with 2.5 cm tall border. The platform was
fastened to a metal frame with casters attached and stood 95 cm
above the floor. It was surrounded by a beige curtain to block
visual cues in the testing room. Velcro was used to fasten the sand-
filled bowls to the platform and stop the rats from spilling the
sand. Pieces of Velcro were equally spaced along the edge of the
platform (one piece in each corner and five additional pieces on
each side) and the bowls for a given trial were placed randomly on
the pieces of Velcro.
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ODORS
Odors were mixed in Premium Play Sand (Quikrete Cement
and Concrete Products, Atlanta, GA) and then placed in white
porcelain bowls (4.5 cm high, 9 cm in diameter) on the platform
as needed for each trial. Sand (100 g) was scented by mixing 0.5 g
of a single dried spice. Twenty-four different scents were used in
the experiments: allspice, anise seed, basil, caraway, celery seed,
cinnamon, cloves (0.1 g), cocoa, coffee, cumin, dill, fennel seed,
garlic, ginger, lemon and herb, marjoram, mustard powder, nut-
meg, onion powder, orange, oregano, paprika, sage, and thyme.
Spices were purchased from a local grocery store. The odors used
each day were selected using a random list generator.1 All subjects
were regularly exposed to all odors.
TRAINING ON THE ODOR SPAN TASK
Previously published protocols were followed closely (Dudchenko
et al., 2000; Davies et al., 2013). Behavioral training was con-
ducted during the light phase with the experimenter blind to the
treatments administered. In all phases of the OST, rats were tested
5–7 days per week with treatment days always occurring 24 h
after a training day except for the CNQX infusions in which both
treatments (vehicle or CNQX) occurred 24 h apart, which was
necessary due to constraints involving the availability of person-
nel. Order effects were not observed in this experiment. Rats were
handled once before dig training for 3 min. Dig Training/Shaping.
First, rats were trained to dig for a cereal reward (Kellogg’s Froot
Loops) in a bowl filled with 100 g of unscented sand. Rats were
placed opposite to a bowl on the platform for three separate
phases. In the first phase, the food reward was positioned on top
of the sand, in the second phase the food reward was incompletely
buried, and in the third phase, the food reward was fully buried in
the sand. Rats were trained until they would consistently dig for
the food reward regardless of bowl position on the platform. This
phase of training took 6–9 days to complete. Odor non-matching-
to-sample. Once the rats reliably dug in unscented bowls, they
moved onto the non-matching-to-sample task. In the sample
phase of a trial, the rat was presented with a bowl of scented
sand randomly positioned on the platform. After the rat dug and
consumed the food reward, it was removed from the platform and
placed behind a curtain to obscure its vision of the platform. The
experimenter then positioned the bowl on the opposite end of the
platform and added a second bowl with a different odor to the
platform. In the choice phase of the trial, the rat was positioned
on the platform opposite to both bowls and then allowed access
to both bowls. A food reward was only in the bowl with the novel
odor for that trial. A choice was scored if the rat dug or placed
its paws or nose on the sand and an error was scored if the rats
chose the previously rewarded odor. The rats were given six non-
matching-to-sample trials each day until they chose the novel
odor on five of the six trials for 3 days.
ODOR SPAN TASK
After performing the non-matching-to-sample task reliably, rats
were introduced to the OST. Trials were run as described for the
non-matching-to-sample task except that bowls with novel odors
1http://www.random.org/lists/
(for that trial) were added and previous bowls remained until
the rat made an error (i.e., dug in any of the bowls except the
novel one) which resulted in the trial ending. Previously presented
bowls were randomly repositioned before each novel bowl was
added to the platform. Therefore, rats could not use spatial cues to
guide their choice of bowl. The span for a given trial was scored as
the number of odor bowls correctly chosen minus 1 bowl. During
training, four rats were transported to the testing room together.
Each rat performed 2 or 3 “spans” per day (rats with high spans
performed 2 spans while rats with low spans performed 3 spans)
with a break between spans occurring while the other rats were
tested. Averaging the spans reduced the variance in our sample
as reported with other memory tests (Winters and Reid, 2010).
The mean of all spans for a given day is reported in the figures.
Once performance reached a span of 7 for two training days (8–
16 days of training), the pharmacological treatments began. On
treatment days, rats were tested for approximately 30 min (1–3
spans) without a break between spans.
PROBE SESSIONS
To determine if the rats were using the odor to solve the task, two
types of probe sessions were conducted. The first probe session
was implemented to test if the scent of the food reward guided
behavior. In this session (3 bowls on the platform: span of 2), the
rats were presented with bowls as described in the OST with the
exception that the food reward was absent from all bowls. When
the rat made a correct choice, the experimenter dropped a food
reward on top of the sand in the correct bowl. The second probe
was implemented to test if the rats were marking the bowls of sand
when they examined them. During a phase in this probe session
(2 bowls on the platform: span 1), all of the bowls and sand were
replaced with new bowls and new sand that contained the same
odors. If rats were marking bowls and sand, their performance
would be reduced on these trials. The rats’ performance was 100%
accurate during both of these probe sessions (data not shown).
SYSTEMIC DRUG ADMINISTRATION
Rats were injected 30 min prior to starting the OST. For the CPP
experiment, rats were injected (i.p.) with either vehicle (saline)
or CPP (10 mg/kg; i.p.). This dose was chosen on the basis of
previous studies (Whitlock et al., 2006). For the Ro 25-6981
experiment, rats were injected (i.p.) with either vehicle (20%
DMSO; 80% H2O) or Ro 25-6981 (6 mg/kg or 10 mg/kg; i.p.;
Wong et al., 2007; Howland and Cazakoff, 2010; Li et al., 2010).
SURGERY AND MPFC INFUSIONS
Surgeries for themPFC andOST experiment were conducted after
the systemic Ro 25-6981 (10 mg/kg) injections experiment. Sub-
jects were anesthetized with isoflurane and prepared for surgery
using previously reported procedures (Cazakoff and Howland,
2011; Davies et al., 2013). Guide cannulae (23 Ga) were bilaterally
inserted above mPFC (AP + 2.60 mm; ML ± 0.70 mm; DV
−3.60 mm; flat skull). Obdurators (0.033 cm diameter stainless
steel wire) were placed into the cannulae to avoid obstruction.
Following surgery, rats were allowed to recover for 8 days before
training resumed. One rat died during surgery. Thus, the n for the
infusion experiments is seven.
Frontiers in Behavioral Neuroscience www.frontiersin.org December 2013 | Volume 7 | Article 183 | 3
Davies et al. Glutamate receptors and odor span
Rats were habituated to the infusion procedure on three
different days during the week before infusions were adminis-
tered (Cazakoff and Howland, 2011; Davies et al., 2013). Infu-
sions were achieved by inserting custom made needles (30 Ga
stainless steel tubing) linked via PE-50 tubing to an infusion
pump (PHD 2000, Harvard Apparatus, Holliston, MA) 1 mm
past the end of the cannulae. Needles were inserted into both
cannula then delivery of Ro 25-6981, CNQX or the vehicle
into the mPFC was initiated (0.5 μl in 1 min). The infusion
needles were left in place for an additional minute after the
infusion to permit diffusion of the drug. Rats were tested on the
OST 15 min following brain infusions. Ro 25-6981 (2.5 μg/0.5
μl; Zhang et al., 2008) and vehicle (12% DMSO; 88% PBS)
were given in a counterbalanced order followed by CNQX (1.25
μg/0.5 μl; Ho et al., 2011) and vehicle (PBS) which were also
counterbalanced.
Following testing in all conditions, the rats were sacri-
ficed with isoflurane and perfused with saline. Brains were
removed and post-fixed in a 10% formalin-10% sucrose
solution. Brains were sectioned on a sliding microtome
and infusion sites were determined using standard protocols
with reference to a rat brain atlas (Paxinos and Watson,
1997).
DATA ANALYSIS
Odor spans and latencies to choose the first bowl were manually
recorded during testing and entered into Microsoft Excel (2010)
and Statistical Package for the Social Sciences (SPSS; version
19.0) for analysis. All descriptive values are reported as means
± standard error of the mean. Comparisons were done using
paired t-tests. Analysis of the spans for baseline sessions before
the various treatments were compared using a repeated measures
ANOVA followed by Neuman Keuls post-hoc tests (Figure 1C).
Statistical tests were considered significant if p values were <
0.05.
RESULTS
TRAINING
After dig training, we trained rats in the non-matching-to-sample
task until they selected the novel odor in 5/6 trials for three
sessions (mean = 7.13 days; range = 6–9 days). Rats were then
trained on the OST (Figure 1A) for a mean of 12.38 sessions
(range, 8–16 days). During the 7 days immediately prior to the
first treatment, the rats reached a span of approximately 7 odors
(Figure 1B), as previously reported when sand-filled bowls are
used (Rushforth et al., 2010, 2011; Davies et al., 2013).
Figure 1C displays the spans of the rats’ baseline sessions.
Over the 8 weeks of repeated testing (Table 1), we noticed a
significant increase in span on the baseline sessions (F(4, 28)
= 7.06, p < 0.001). Average baseline spans increased from a
mean of 7.00 ± 0.5 the day before CPP treatment to 12.14 ±
1.6 before CNQX treatment. It should be noted that surgery
was performed on the rats between the second systemic admin-
istration of Ro 25-6918 and first intracranial injection of Ro
25-6981 into the mPFC. Surgery had no measureable effect on
the average span observed following the retraining period (two
sessions).
SYSTEMIC INJECTION OF EITHER CPP OR RO 25-6981 IMPAIRS ODOR
SPAN
Systemic injections of CPP (10 mg/kg; i.p.) impaired span capac-
ity (Figure 2A) without affecting latency to dig in the OST
(Figure 2B). Following CPP rats had a span of 4.64 ± 0.6 odors
which was significantly lower than when the rats were injected
with saline (7.65 ± 0.9 odors; t(7) = 5.19, p < 0.001). Latencies
to begin digging in bowls did not differ between treatments
(Figure 2B; Saline = 5.17 ± 0.9 s; CPP = 4.03 ± 0.4 s; t(7) =
1.12, n.s.).
To test the effect of blocking only NMDA receptors containing
GluN2B subunits, two doses of Ro 25-6981 were administered
systemically (i.p.). A trend of decreased odor span was found
following administration of the 6 mg/kg dose (Figure 2C; Veh
= 12.07 ± 1.8 odors; Ro 25-6981 = 9.14 ± 1.0); however, this
difference was not significant (t(7) = 1.41, n.s.). A higher dose
of Ro 25-6981 (10 mg/kg) significantly reduced span in rats
(Figure 2E; Veh = 13.19 ± 1.5; Ro 25-6981 = 6.90 ± 2.2; t(7)
= 3.55, p = 0.009). Latency for the rats to begin digging in a
bowl did not differ between treatments for either dose (Figure 2D
t(7) = 0.32, n.s.; Figure 2F t(7) = −0.42, n.s.). Thus, systemic
blockade of GluN2B-containing NMDA receptors impaired odor
span capacity without affecting latency in the OST.
RO 25-6981 OR CNQX INFUSIONS IN MPFC IMPAIR PERFORMANCE OF
THE OST
In an effort to delineate the critical brain regions that underlie dis-
ruption in odor span observed following systemic administration
of NMDA receptor antagonists, mPFC infusions of Ro 25-6981
were performed. Intra-mPFC Ro 25-6981 infusions impaired
span capacity but not latency on the OST (Figures 3A, B). A
robust decrease in span was observed in six out of the seven rats.
When all seven rats were considered, spans decreased from 12.43
± 2.5 for vehicle infusion to 5.95 ± 1.6 for Ro 25-6981 infusion
(Figure 3A), an approximate 50% decrease in mean span. This
difference was close to significant (t(6) = 2.21, p = 0.069). When
the rat that showed the opposite pattern of behavior was removed,
a significant difference was observed (Veh = 14.08 ± 2.3; Ro
25-6981 = 4.95 ± 1.4, t(5) = 6.32, p < 0.001). The latency for
rats to begin digging into bowls did not differ between the two
treatments (Figure 3B; t(6)= −0.40, n.s.).
To test the potential role of mPFC AMPA receptors in span
capacity, CNQX was infused into the mPFC (Figures 3C, D). A
marked reduction in odor span was observed in rats following
CNQX infusions (Veh = 9.71 ± 1.5; CNQX = 4.14 ± 1.4; t(6)
= 5.57, p < 0.001). Latency for rats to begin digging into bowls
following CNQX infusions into the mPFC was also significantly
reduced by CNQX infusions (Veh = 4.29 ± 0.6 s; CNQX = 1.86
± 0.3 s; t(6)= 3.23, p = 0.018).
Figure 3E shows the infusion sites of the rats in the mPFC
OST experiments. Infusion sites were located in the prelimbic,
infralimbic, and dorsal peduncular areas of the mPFC.
DISCUSSION
The present study revealed a series of novel findings: (1) span
capacity of untreated rats significantly increased from a mean
of approximately 7 to a mean of approximately 13 following the
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FIGURE 2 | Effects of systemic NMDA receptor antagonism on
performance of the OST (n = 8). (A) Mean spans of the rats following
saline or CPP treatment (10 mg/kg, i.p.). (B) The mean latency of the rats to
begin digging in a bowl (saline or CPP). (C) Mean spans for the rats
following vehicle (Veh) or Ro 25-6981 (Ro) treatment (6 mg/kg, i.p.) (D) The
mean latency of the rats to begin digging in a bowl during the tests
conducted in C. (E) Mean spans for the rats following each treatment with
either Veh or Ro 25-6981 (10 mg/kg, i.p.). (F) The mean latency of the rats
to begin digging in a bowl (Veh or Ro, 10 mg/kg). * Refers to a significant
difference between treatments (p < 0.05).
first treatment (Figure 1C); (2) systemic injections of the broad
spectrum NMDA receptor antagonist CPP significantly reduced
span capacity (Figure 2A); (3) systemically administered Ro 25-
6981 dose-dependently impaired odor span (Figures 2C, E);
(4) GluN2B subunit-containing NMDA receptors in the mPFC
may be involved in performance of the OST because Ro 25-
6981 infusions into the mPFC marginally impaired span capacity
(Figure 3A); (5) blocking AMPA receptors in mPFC with CNQX
FIGURE 3 | OST performance following infusions of either Ro 25-6981
or CNQX into mPFC (n = 7). (A) Mean spans of the rats following vehicle
(Veh) or Ro 25-6981 infusions into mPFC. (B) The mean latency of the rats
to begin digging in a bowl for the treatments in A. (C) Mean spans for the
rats following treatment with either Veh or CNQX into the mPFC. (D) The
mean latency for the rats to begin digging in a bowl (Veh or CNQX; mPFC
infusion). (E) Infusion sites in the mPFC. Numbers refer to the
anterior-posterior location of the plates relative to bregma. * Refers to a
significant difference between treatments (p < 0.05).
infusions impaired span capacity and reduced latency to dig in the
task compared to vehicle infusions (Figures 3C, D).
PERFORMANCE OF RATS ON THE ODOR SPAN TASK
Rats in the present experiment initially performed similarly to
those reported in a previous publication from our group (Davies
et al., 2013) and others using the version of the OST that requires
the rats to dig in scented sand (Rushforth et al., 2010, 2011).
By testing the rats on 1–3 spans per day for a maximum of
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30 min, within-session variability was reduced in our study, a
characteristic of the OST that has been discussed previously
(Dudchenko et al., 2000). We did not observe a consistent pattern
of span length over the spans tested on a given day, although it
should be emphasized that rats with high spans would not receive
a 2nd or 3rd span on a given day given the time constraint (30min
testing/day) we imposed. The results from the pharmacological
experiments include the mean of all spans tested for each animal
on a given day. If just the first span is considered for the baseline
and treatment days, all results are the same as those reported for
the mean daily spans (data not shown).
Unexpectedly, the mean baseline spans of the rats in the
present study increased to approximately 12 odors with further
training (Figure 1C) and as a result performance was not stable
before the systemic CPP treatment was given. While it is not
clear why a higher span capacity was achieved in the present
experiments, probe sessions showed that rats were not using either
the odor of the buried food or some unknown feature of the bowls
to solve the task. Rats in our previous study (Davies et al., 2013)
underwent the same stereotaxic surgery to implant cannulae in
the mPFC; thus, effects related to that procedure are likely not
involved. The present experiment was conducted in a new facility
(with the identical platform and bowls) as our previous report,
although the specific reasons why span capacity would be altered
in the new facility are unclear. In any case, performance of the rats
in the present study is within the normal range for our method of
training the OST. When a testing procedure is used that allows
rats to continue sampling odors after an error is committed,
spans higher than 15 have been reported (Dudchenko et al., 2000;
Turchi and Sarter, 2000). Results using a different version of the
OST that limits the number of stimuli available on each trial
also suggests that maximum span capacity is higher than the
previously reported 7–9 odors (April et al., 2013), a result we
would expect with that procedure.
This group of rats may have also become better able to rec-
ognize the 24 odors used in the task over the extended training
they received. On a given day, the odors used for a given span are
randomly selected but the same odors are used repeatedly over the
weeks of training. Thus, the experience of the rats with the odors
may influence their performance. However, this experiment did
not assess if the increase of span capacity was due to familiarly
with the odors, continuing rule learning, or strengthening of
memory. One future test of this hypothesis would be to introduce
rats to a series of novel odors after extended training as we
conducted in this experiment. If the familiarity of the rats with
the “well-trained” odors affected their performance, a reduction
in span may be observed when the rats were tested with a series of
entirely novel odors.
IONOTROPIC GLUTAMATE RECEPTORS IN MPFC ARE NECESSARY FOR
ODOR SPAN
The impairment of odor span following treatment with the
NMDA receptor antagonist CPP (Figure 2A) is consistent with
previously reported effects of the non-competitive NMDA
receptor antagonists MK-801 (acute treatment; MacQueen et al.,
2011; Galizio et al., 2013) and ketamine (repeated injections)
on odor span (Rushforth et al., 2011). Impairments in aspects
of working memory other than capacity are well documented
following treatment with NMDA receptor antagonists (Li et al.,
1997; Doyle et al., 1998; Moghaddam and Adams, 1998; Aura and
Riekkinen, 1999; Smith et al., 2011).
The role of NMDA receptor subtypes in cognition has been
the subject of intense investigation since it was first shown
GluN2B receptors mediate long term depression (LTD) and
GluN2A receptors mediate LTP in the hippocampus (Liu et al.,
2004). For the first time, we demonstrate that blocking NMDA
receptors specifically containing GluN2B subunits systemically
impairs odor span capacity (Figure 2E) while infusions of
Ro 25-6981 in mPFC marginally impair odor span capacity
(Figure 3A). We used the compound Ro 25-6981 which is 5,000
times more selective for GluN2B subunits compared to GluN2A
subunits (Fischer et al., 1997). Thus, while we cannot exclude the
possibility that some GluN2A-containing NMDA receptors were
affected, it is highly likely that the effects we observed on odor
span were due to effects of Ro 25-6981 on GluN2B-containing
receptors. Previously, we found a systemic dose of 6 mg/kg
of Ro 25-6981 was sufficient to prevent the stress-induced
disruptions of spatial (Wong et al., 2007; Howland and Cazakoff,
2010) and object memory retrieval (Howland and Cazakoff,
2010). Differences between the presumed site of drug action
(hippocampus vs. mPFC) or the specific cognitive operations
examined (spatial and recognition memory vs. working memory)
may have contributed to the results observed at the dose of 6
mg/kg. Higher doses, including 10 mg/kg, also cause behavioral
changes in the forced swim test (Li et al., 2010). Our results
compliment a study from Cui and colleagues showing increased
span capacity in mice with overexpression of GluN2B-containing
NMDA receptors in the forebrain (Cui et al., 2011). Others have
demonstrated a role for mPFC GluN2B receptors in trace fear
conditioning, which is similar to working memory as it involves
a temporal gap between the conditioned and unconditioned
stimuli (Gilmartin and Helmstetter, 2010; Gilmartin et al., 2013).
However, at least two reports have failed to observe deficits in
working memory as assessed using operant delayed-match-to-
position paradigms following systemic administration of GluN2B
antagonists (Doyle et al., 1998; Smith et al., 2011).
The role of GluN2B-containing NMDA receptors in mPFC
neural activity is under investigation. In rodent hippocampus,
GluN2B-containing NMDA receptors may be more frequently
localized to extrasynaptic areas and become activated when
extracellular glutamate levels are elevated such as during acute
stress (Yang et al., 2005; Wong et al., 2007; Howland and Wang,
2008). In rodent mPFC, NMDA receptors containing GluN2B
subunits are found on pyramidal cells and interneurons and thus
may be important for cognitive functions, including working
memory. Broad spectrum NMDA receptor antagonists alter the
firing properties of mPFC pyramidal cells in rodents by reducing
burst firing (Jackson et al., 2004) while increasing basal firing
rate (Jackson et al., 2004; Homayoun and Moghaddam, 2007).
Interestingly, GluN2A receptors have been shown to critically
modulate the increased gamma oscillations observed in cortex
following NMDA receptor blockade (Kocsis, 2012). In monkeys,
GluN2B-containing receptors are located in the synapses of
pyramidal neurons (Wang et al., 2013). Using electrophysiological
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recordings in freely behaving monkeys, direct application of Ro
25-6981 to the dorsolateral PFC was shown to impair perfor-
mance of the delayed occulomotor response task and reduce firing
of delay neurons in dorsolateral PFC (Wang et al., 2013). Similar
results were observed following the systemic administration of
ketamine (Wang et al., 2013). Whether similar effects of GluN2B
antagonists on neural activity are observed in rodents is difficult
to predict as response neurons are more commonly found in the
rodent mPFC (Caetano et al., 2012; but see Devilbiss et al., 2012).
In the final experiment, we show that blocking mPFC AMPA
receptors impairs span capacity (Figure 3C) while also reducing
the latency for rats to make a choice. In previous studies, the
effects of manipulating AMPA receptor activity in the mPFC on
working memory have been inconsistent. Medial PFC infusions of
CNQX impair working memory assessed by delayed alternation
(Romanides et al., 1999) while systemic administration of
the AMPA receptor antagonist with YM90K failed to alter
performance of a radial armmaze task with or without a delay (Li
et al., 1997). Application of CNQX to the dorsolateral prefrontal
cortex in monkeys produced mixed results on neural activity in
the delayed occulomotor response task (Wang et al., 2013). CNQX
significantly reduced the firing rate of cue cells; however, it had
varied results on response and delay cells. In addition, when rats
were treated with CNQX in the OST, they showed reduced latency
to dig, which may result from a psychomotor effect from CNQX;
thus, caution is warranted when interpreting the impaired span
capacity data. Whether this finding reflects increased impulsivity
is unclear; however, AMPA receptor blockade in the infralimbic
sub-region of the mPFC does not cause an impulsive phenotype
in the five choice serial reaction time task (Murphy et al., 2012).
CONCLUSION
Previous research using various tasks including the OST
implicates the mPFC as an essential substrate for working
memory (Kolb, 1991; Seamans et al., 1995; Floresco et al., 1997;
Aujla and Beninger, 2001; Davies et al., 2013). The present
results suggest a role for GluN2B-containing NMDA receptors
and AMPA receptors in the mPFC for span capacity. Caution
is warranted regarding the involvement of AMPA receptors
in the mPFC during the OST given that both span capacity
and latency decreased with CNQX infusions. The CNTRICS
group has specified working memory capacity as a construct
that needs more basic research before being incorporated into
translational sequence for drug development (Barch and Smith,
2008; Dudchenko et al., 2012). Thus, these results may aid in
novel therapeutic development for persons with schizophrenia.
AUTHOR CONTRIBUTIONS
Don A. Davies designed the experiments, conducted research,
analyzed data, and co-wrote the manuscript. Quentin Greba
conducted research. John G. Howland designed the experiments,
co-wrote the manuscript, and supervised the project.
ACKNOWLEDGMENTS
This work was supported by a Discovery Grant from the Nat-
ural Sciences and Engineering Research Council of Canada and
Open Operating Grant from the Canadian Institutes for Health
Research to John G. Howland. John G. Howland is a Canadian
Institutes of Health Research New Investigator.
REFERENCES
April, L. B., Bruce, K., and Galizio,M. (2013). The magic number 70 (plus or minus
20): variables determining performance in the rodent odor span task. Learn.
Motiv. 44, 143–158. doi: 10.1016/j.lmot.2013.03.001
Aujla, H., and Beninger, R. J. (2001). Hippocampal-prefrontocortical circuits: PKA
inhibition in the prefrontal cortex impairs delayed nonmatching in the radial
maze in rats. Behav. Neurosci. 115, 1204–1211. doi: 10.1037/0735-7044.115.6.
1204
Aura, J., and Riekkinen, P., Jr. (1999). Blockade of NMDA receptors located at
the dorsomedial prefrontal cortex impairs spatial working memory in rats.
Neuroreport 10, 243–248. doi: 10.1097/00001756-199902050-00008
Baddeley, A. (2003). Working memory: looking back and looking forward. Nat.
Rev. Neurosci. 4, 829–839. doi: 10.1038/nrn1201
Barch, D. M., and Smith, E. (2008). The cognitive neuroscience of working
memory: relevance to CNTRICS and schizophrenia. Biol. Psychiatry 64, 11–17.
doi: 10.1016/j.biopsych.2008.03.003
Barch, D. M., Berman, M. G., Engle, R., Jones, J. H., Jonides, J., Macdonald, A., III,
et al. (2009). CNTRICS final task selection: working memory. Schizophr. Bull.
35, 136–152. doi: 10.1093/schbul/sbn153
Caetano, M. S., Horst, N. K., Harenberg, L., Liu, B., Arnsten, A. F., and Laubach,
M. (2012). Lost in transition: aging-related changes in executive control by the
medial prefrontal cortex. J. Neurosci. 32, 3765–3777. doi: 10.1523/jneurosci.
6011-11.2012
Cazakoff, B. N., and Howland, J. G. (2011). AMPA receptor endocytosis in rat
perirhinal cortex underlies retrieval of object memory. Learn. Mem. 18, 688–
692. doi: 10.1101/lm.2312711
Chey, J., Lee, J., Kim, Y. S., Kwon, S. M., and Shin, Y. M. (2002). Spatial working
memory span, delayed response and executive function in schizophrenia. Psy-
chiatry Res. 110, 259–271. doi: 10.1016/s0165-1781(02)00105-1
Cui, Y., Jin, J., Zhang, X., Xu, H., Yang, L., Du, D., et al. (2011). Forebrain NR2B
overexpression facilitating the prefrontal cortex long-term potentiation and
enhancing working memory function in mice. PLoS One 6:e20312. doi: 10.
1371/journal.pone.0020312
Davies, D. A., Molder, J. J., Greba, Q., and Howland, J. G. (2013). Inactivation of
medial prefrontal cortex or acute stress impairs odor span in rats. Learn. Mem.
20, 665–669. doi: 10.1101/lm.032243.113
D’Esposito, M. (2007). From cognitive to neural models of working memory.
Philos. Trans. R. Soc. Lond. B Biol. Sci. 362, 761–772. doi: 10.1098/rstb.2007.2086
Devilbiss, D. M., Jenison, R. L., and Berridge, C. W. (2012). Stress-induced
impairment of a working memory task: role of spiking rate and spiking history
predicted discharge. PLoS Comput. Biol. 8:e1002681. doi: 10.1371/journal.pcbi.
1002681
Doyle, K. M., Feerick, S., Kirkby, D. L., Eddleston, A., and Higgins, G. A. (1998).
Comparison of various N-methyl-D-aspartate receptor antagonists in a model
of short-term memory and on overt behaviour. Behav. Pharmacol. 9, 671–681.
doi: 10.1097/00008877-199812000-00003
Dudchenko, P. A. (2004). An overview of the tasks used to test working memory in
rodents. Neurosci. Biobehav. Rev. 28, 699–709. doi: 10.1016/j.neubiorev.2004.09.
002
Dudchenko, P. A., Talpos, J., Young, J., and Baxter, M. G. (2012). Animal mod-
els of working memory: a review of tasks that might be used in screen-
ing drug treatments for the memory impairments found in schizophrenia.
Neurosci. Biobehav. Rev. doi: 10.1016/j.neubiorev.2012.03.003. [Epub ahead
of print].
Dudchenko, P. A., Wood, E. R., and Eichenbaum,H. (2000). Neurotoxic hippocam-
pal lesions have no effect on odor span and little effect on odor recognition
memory but produce significant impairments on spatial span, recognition and
alternation. J. Neurosci. 20, 2964–2977.
Fischer, G., Mutel, V., Trube, G., Malherbe, P., Kew, J. N., Mohacsi, E., et al. (1997).
Ro 25–6981, a highly potent and selective blocker of N-methyl-D-aspartate
receptors containing the NR2B subunit. Characterization in vitro. J. Pharmacol.
Exp. Ther. 283, 1285–1292.
Floresco, S. B., Seamans, J. K., and Phillips, A. G. (1997). Selective roles for
hippocampal, prefrontal cortical and ventral striatal circuits in radial-arm maze
tasks with or without a delay. J. Neurosci. 17, 1880–1890.
Frontiers in Behavioral Neuroscience www.frontiersin.org December 2013 | Volume 7 | Article 183 | 7
Davies et al. Glutamate receptors and odor span
Galizio, M., Deal, M., Hawkey, A., and April, B. (2013). Working memory in the
odor span task: effects of chlordiazepoxide, dizocilpine (MK801), morphine and
scopolamine. Psychopharmacology (Berl) 225, 397–406. doi: 10.1007/s00213-
012-2825-7
Gilmartin, M. R., and Helmstetter, F. J. (2010). Trace and contextual fear condi-
tioning require neural activity and NMDA receptor-dependent transmission
in the medial prefrontal cortex. Learn. Mem. 17, 289–296. doi: 10.1101/lm.
1597410
Gilmartin, M. R., Kwapis, J. L., and Helmstetter, F. J. (2013). NR2A- and NR2B-
containing NMDA receptors in the prelimbic medial prefrontal cortex differ-
entially mediate trace, delay and contextual fear conditioning. Learn. Mem. 20,
290–294. doi: 10.1101/lm.030510.113
Gold, J. M., Hahn, B., Zhang, W. W., Robinson, B. M., Kappenman, E. S., Beck,
V. M., et al. (2010). Reduced capacity but spared precision and maintenance
of working memory representations in schizophrenia. Arch. Gen. Psychiatry 67,
570–577. doi: 10.1001/archgenpsychiatry.2010.65
Goldman-Rakic, P. S. (1996). Regional and cellular fractionation of working
memory. Proc. Natl. Acad. Sci. U S A 93, 13473–13480. doi: 10.1073/pnas.93.
24.13473
Ho, J. W., Narduzzo, K. E., Outram, A., Tinsley, C. J., Henley, J. M., Warburton, E.
C., et al. (2011). Contributions of area Te2 to rat recognition memory. Learn.
Mem. 18, 493–501. doi: 10.1101/lm.2167511
Homayoun, H., and Moghaddam, B. (2007). NMDA receptor hypofunction pro-
duces opposite effects on prefrontal cortex interneurons and pyramidal neurons.
J. Neurosci. 27, 11496–11500. doi: 10.1523/jneurosci.2213-07.2007
Honore, T., Davies, S. N., Drejer, J., Fletcher, E. J., Jacobsen, P., Lodge, D., et al.
(1988). Quinoxalinediones: potent competitive non-NMDA glutamate receptor
antagonists. Science 241, 701–703. doi: 10.1126/science.2899909
Howland, J. G., and Cazakoff, B. N. (2010). Effects of acute stress and GluN2B-
containing NMDA receptor antagonism on object and object-place recognition
memory. Neurobiol. Learn. Mem. 93, 261–267. doi: 10.1016/j.nlm.2009.10.006
Howland, J. G., andWang, Y. T. (2008). Synaptic plasticity in learning and memory:
stress effects in the hippocampus. Prog. Brain Res. 169, 145–158. doi: 10.
1016/s0079-6123(07)00008-8
Huntley, J. D., and Howard, R. J. (2010). Working memory in early Alzheimer’s
disease: a neuropsychological review. Int. J. Geriatr. Psychiatry 25, 121–132.
doi: 10.1002/gps.2314
Jackson, M. E., Homayoun, H., and Moghaddam, B. (2004). NMDA receptor
hypofunction produces concomitant firing rate potentiation and burst activity
reduction in the prefrontal cortex. Proc. Natl. Acad. Sci. U S A 101, 8467–8472.
doi: 10.1073/pnas.0308455101
Kocsis, B. (2012). Differential role of NR2A and NR2B subunits in N-methyl-
D-aspartate receptor antagonist-induced aberrant cortical gamma oscillations.
Biol. Psychiatry 71, 987–995. doi: 10.1016/j.biopsych.2011.10.002
Kolb, B. (1991). Animal models for human PFC-related disorders. Prog. Brain Res.
85, 501–519. doi: 10.1016/S0079-6123(08)62697-7
Lehmann, J., Schneider, J., McPherson, S., Murphy, D. E., Bernard, P., Tsai, C.,
et al. (1987). CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor
antagonist: characterization in vitro and in vivo. J. Pharmacol. Exp. Ther. 240,
737–746.
Li, H. B., Matsumoto, K., Yamamoto, M., and Watanabe, H. (1997). NMDA but
not AMPA receptor antagonists impair the delay-interposed radial maze per-
formance of rats. Pharmacol. Biochem. Behav. 58, 249–253. doi: 10.1016/s0091-
3057(97)00015-4
Li, N., Lee, B., Liu, R. J., Banasr, M., Dwyer, J. M., Iwata, M., et al. (2010).
mTOR-dependent synapse formation underlies the rapid antidepressant effects
of NMDA antagonists. Science 329, 959–964. doi: 10.1126/science.1190287
Liu, L.,Wong, T. P., Pozza,M. F., Lingenhoehl, K., Wang, Y., Sheng, M., et al. (2004).
Role of NMDA receptor subtypes in governing the direction of hippocampal
synaptic plasticity. Science 304, 1021–1024. doi: 10.1126/science.1096615
MacQueen, D. A., Bullard, L., and Galizio, M. (2011). Effects of dizocilpine
(MK801) on olfactory span in rats. Neurobiol. Learn. Mem. 95, 57–63. doi: 10.
1016/j.nlm.2010.11.004
Moghaddam, B., and Adams, B. W. (1998). Reversal of phencyclidine effects by a
group II metabotropic glutamate receptor agonist in rats. Science 281, 1349–
1352. doi: 10.1126/science.281.5381.1349
Murphy, E. R., Fernando, A. B., Urcelay, G. P., Robinson, E. S., Mar, A. C., Theobald,
D. E., et al. (2012). Impulsive behaviour induced by both NMDA receptor
antagonism and GABAA receptor activation in rat ventromedial prefrontal
cortex. Psychopharmacology (Berl) 219, 401–410. doi: 10.1007/s00213-011-
2572-1
Paxinos, G., and Watson, C. (1997). The Rat Brain in Stereotaxic Coordinates.
Amsterdam: Elsevier.
Romanides, A. J., Duffy, P., and Kalivas, P. W. (1999). Glutamatergic and dopamin-
ergic afferents to the prefrontal cortex regulate spatial working memory in rats.
Neuroscience 92, 97–106. doi: 10.1016/s0306-4522(98)00747-7
Rushforth, S. L., Allison, C., Wonnacott, S., and Shoaib, M. (2010). Subtype-
selective nicotinic agonists enhance olfactory working memory in normal rats:
a novel use of the odour span task. Neurosci. Lett. 471, 114–118. doi: 10.1016/j.
neulet.2010.01.022
Rushforth, S. L., Steckler, T., and Shoaib, M. (2011). Nicotine improves working
memory span capacity in rats following sub-chronic ketamine exposure. Neu-
ropsychopharmacology 36, 2774–2781. doi: 10.1038/npp.2011.224
Seamans, J. K., Floresco, S. B., and Phillips, A. G. (1995). Functional differences
between the prelimbic and anterior cingulate regions of the rat prefrontal cortex.
Behav. Neurosci. 109, 1063–1073. doi: 10.1037/0735-7044.109.6.1063
Smith, J. W., Gastambide, F., Gilmour, G., Dix, S., Foss, J., Lloyd, K., et al. (2011). A
comparison of the effects of ketamine and phencyclidine with other antagonists
of the NMDA receptor in rodent assays of attention and working memory.
Psychopharmacology (Berl) 217, 255–269. doi: 10.1007/s00213-011-2277-5
Turchi, J., and Sarter, M. (2000). Cortical cholinergic inputs mediate processing
capacity: effects of 192 IgG-saporin-induced lesions on olfactory span perfor-
mance. Eur. J. Neurosci. 12, 4505–4514. doi: 10.1111/j.1460-9568.2000.01347.x
Wang, M., Yang, Y., Wang, C. J., Gamo, N. J., Jin, L. E., Mazer, J. A., et al. (2013).
NMDA receptors subserve persistent neuronal firing duringworkingmemory in
dorsolateral prefrontal cortex. Neuron 77, 736–749. doi: 10.1016/j.neuron.2012.
12.032
Whitlock, J. R., Heynen, A. J., Shuler, M. G., and Bear, M. F. (2006). Learning
induces long-term potentiation in the hippocampus. Science 313, 1093–1097.
doi: 10.1126/science.1128134
Winters, B. D., and Reid, J. M. (2010). A distributed cortical representation
underlies crossmodal object recognition in rats. J. Neurosci. 30, 6253–6261.
doi: 10.1523/jneurosci.6073-09.2010
Wong, T. P., Howland, J. G., Robillard, J. M., Ge, Y., Yu, W., Titterness, A. K., et
al. (2007). Hippocampal long-term depression mediates acute stress-induced
spatial memory retrieval impairment. Proc. Natl. Acad. Sci. U S A 104, 11471–
11476. doi: 10.1073/pnas.0702308104
Yang, C. H., Huang, C. C., and Hsu, K. S. (2005). Behavioral stress enhances
hippocampal CA1 long-term depression through the blockade of the glutamate
uptake. J. Neurosci. 25, 4288–4293. doi: 10.1523/jneurosci.0406-05.2005
Young, J. W., Kerr, L. E., Kelly, J. S., Marston, H. M., Spratt, C., Finlayson, K., et al.
(2007). The odour span task: a novel paradigm for assessing working memory
in mice. Neuropharmacology 52, 634–645. doi: 10.1016/j.neuropharm.2006.09.
006
Zhang, X. H., Wu, L. J., Gong, B., Ren, M., Li, B. M., and Zhuo, M. (2008).
Induction- and conditioning-protocol dependent involvement of NR2B-
containing NMDA receptors in synaptic potentiation and contextual fear mem-
ory in the hippocampal CA1 region of rats. Mol. Brain 1:9. doi: 10.1186/1756-
6606-1-9
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be
construed as a potential conflict of interest.
Received: 14 October 2013; paper pending published: 23 October 2013; accepted: 13
November 2013; published online: 02 December 2013.
Citation: Davies DA, Greba Q and Howland JG (2013) GluN2B-containing NMDA
receptors and AMPA receptors in medial prefrontal cortex are necessary for odor span
in rats. Front. Behav. Neurosci. 7:183. doi: 10.3389/fnbeh.2013.00183
This article was submitted to the journal Frontiers in Behavioral Neuroscience.
Copyright © 2013 Davies, Greba and Howland. This is an open-access article dis-
tributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Behavioral Neuroscience www.frontiersin.org December 2013 | Volume 7 | Article 183 | 8
